Established in 1956, Hisun Pharmaceutical manufactures over 100 APIs with a focus on oncology, anti-infectives, cardiovascular health, immunosuppressants and animal healthcare. The company has built a robust technology platform offering CMO/CDMO services in both fermentation and synthetic processes, with world-class fermentation capabilities from strain development to large-scale production, leveraging its pharmaceutical expertise in microbial fermentation to support the nutraceuticals, dietary supplements and cosmetics sectors.

No comments available.
Leave your rating & comment